MedTrace Logo

Total Body Albumin Measurement Utilizing a Modification of the BVA 100 Blood Volume Analyzer

NCT01542749 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2012-03-02

No results posted yet for this study

Summary

The DAXOR Corporation manufactures and distributes a blood volume analyzer. The analysis is based on the tracer dilution principle utilizing radioiodine labeled human serum albumin. In addition to calculating human blood volume it is hypothesized that measurement of the dilution of the tracer can also yield an accurate measurement of total body albumin.

Conditions

Sponsors & Collaborators

  • Daxor Corporation

    lead INDUSTRY

Principal Investigators

  • Joseph Feldschuh, MD · Daxor Corporation

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2010-08-31
Completion
2012-01-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01542749 on ClinicalTrials.gov